Sepsis: Epidemiology, Pathophysiology, Classification, Biomarkers and Management
暂无分享,去创建一个
Matthew Brennan | Anuj Vohra | Noah Pirozzi | Nima Rejali | Trevor McGinley | Murali G. Krishna | M. Brennan | Anuj Vohra | N. Pirozzi | Nima Rejali | Trevor McGinley | Murali G. Krishna
[1] S. Lemeshow,et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study , 2014, Intensive Care Medicine.
[2] Xia Zheng,et al. Passive leg raising as an indicator of fluid responsiveness in patients with severe sepsis. , 2012, World journal of emergency medicine.
[3] D. Angus,et al. Epidemiology of severe sepsis , 2013, Virulence.
[4] P. Marik,et al. The use of bioreactance and carotid Doppler to determine volume responsiveness and blood flow redistribution following passive leg raising in hemodynamically unstable patients. , 2013, Chest.
[5] M. J. Hall,et al. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. , 2011, NCHS data brief.
[6] E. Ivers,et al. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .
[7] Brian H Cuthbertson,et al. Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.
[8] J. Vincent,et al. Sepsis biomarkers: a review , 2010, Critical care.
[9] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.
[10] P. Squara,et al. Noninvasive cardiac output monitoring (NICOM): a clinical validation , 2007, Intensive Care Medicine.
[11] Mbbs Md FRCPath Donald N. Pritzker Vinay Kumar. Robbins and Cotran pathologic basis of disease , 2015 .
[12] A. Rodríguez-Rodríguez,et al. The utility of C-reactive protein and procalcitonin for sepsis diagnosis in critically burned patients: A preliminary study. , 2015, Plastic surgery.
[13] G. Patel,et al. Systemic steroids in severe sepsis and septic shock. , 2012, American journal of respiratory and critical care medicine.
[14] Mitchell M. Levy,et al. Lactate Measurements in Sepsis-Induced Tissue Hypoperfusion: Results From the Surviving Sepsis Campaign Database* , 2015, Critical care medicine.
[15] D. Burkhoff,et al. Multicenter Evaluation of Noninvasive Cardiac Output Measurement by Bioreactance Technique , 2008, Journal of Clinical Monitoring and Computing.
[16] Michael Bailey,et al. Goal-directed resuscitation for patients with early septic shock. , 2014, The New England journal of medicine.
[17] P. Pronovost,et al. Long-term mortality and quality of life in sepsis: A systematic review* , 2010, Critical care medicine.
[18] A. Rhodes,et al. Outcomes from implementing early goal-directed therapy for severe sepsis and septic shock: a 4-year observational cohort study , 2012, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.
[19] Stephane Heritier,et al. Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.
[20] F. Tubach,et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial , 2010, The Lancet.
[21] B. Stoll,et al. Neonatal sepsis: progress towards improved outcomes. , 2014, The Journal of infection.
[22] M. Meisner. Update on Procalcitonin Measurements , 2014, Annals of laboratory medicine.
[23] Michael B. Rothberg,et al. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007 , 2012, Critical care medicine.
[24] G. Decavalas,et al. Severe Sepsis and Septic Shock , 2018 .
[25] W Frank Peacock,et al. Hemodynamic changes as a diagnostic tool in acute heart failure--a pilot study. , 2012, The American journal of emergency medicine.
[26] Kathryn M Rowan,et al. The Protocolised Management in Sepsis (ProMISe) trial statistical analysis plan. , 2013, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.
[27] E. Polati,et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis. , 2003, Critical care medicine.
[28] M. Levy,et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.
[29] G. Escobar,et al. Hospital deaths in patients with sepsis from 2 independent cohorts. , 2014, JAMA.
[30] Jay Wook Lee,et al. Fluid and Electrolyte Disturbances in Critically Ill Patients , 2010, Electrolyte & blood pressure : E & BP.
[31] Peter Schlattmann,et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.
[32] R. Grover. EFFECTS OF HYPOXIA ON VENTILATION AND CARDIAC OUTPUT * , 1965, Annals of the New York Academy of Sciences.
[33] Russell R. Miller,et al. Multicenter implementation of a severe sepsis and septic shock treatment bundle. , 2013, American journal of respiratory and critical care medicine.
[34] H. Hirasawa,et al. Blood glucose control in patients with severe sepsis and septic shock. , 2009, World journal of gastroenterology.
[35] Amber E Barnato,et al. A randomized trial of protocol-based care for early septic shock. , 2014, The New England journal of medicine.
[36] J. Teboul,et al. The respiratory variation in inferior vena cava diameter as a guide to fluid therapy , 2004, Intensive Care Medicine.
[37] M. Cove,et al. Fluid Resuscitation in Sepsis: Reexamining the Paradigm , 2014, BioMed research international.
[38] Xavier Monnet,et al. Hemodynamic parameters to guide fluid therapy , 2011, Annals of intensive care.
[39] J. Yim,et al. Prognostic Value of Central Venous Oxygen Saturation and Blood Lactate Levels Measured Simultaneously in the Same Patients with Severe Systemic Inflammatory Response Syndrome and Severe Sepsis , 2014, Lung.
[40] C. Sprung,et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.
[41] D. Chemla,et al. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. , 2000, American journal of respiratory and critical care medicine.
[42] F. Gao,et al. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study , 2005, Critical care.